Author/Authors :
Roy, Andrew K. Institut Cardiovasculaire Paris-Sud - Hopital Prive Jacques Cartier, Massy, France , Garot, Jerome Institut Cardiovasculaire Paris-Sud - Hopital Prive Jacques Cartier, Massy, France , Neylon, Antoinette Institut Cardiovasculaire Paris-Sud - Hopital Prive Jacques Cartier, Massy, France , Spaziano, Marco Institut Cardiovasculaire Paris-Sud - Hopital Prive Jacques Cartier, Massy, France , Sawaya, Fadi J. Institut Cardiovasculaire Paris-Sud - Hopital Prive Jacques Cartier, Massy, France , Lefèvre, Thierry Institut Cardiovasculaire Paris-Sud - Hopital Prive Jacques Cartier, Massy, France
Abstract :
Progressive dyspnea and hypoxaemia in the subacute phase after transcatheter aortic valve implantation (TAVI) are uncommon
and warrant immediate assessment of valve and prosthesis leaflet function to exclude thrombosis, as well as investigation for other
causes related to the procedure, such as left ventricular dysfunction, pulmonary embolism, and respiratory sepsis. In this case, we
report the observation of a patient presenting two weeks after TAVI with arterial hypoxaemia in an upright position, relieved by
lying flat, and coupled with an intracardiac shunt detected on echocardiography in the absence of pulmonary hypertension, raising
the suspicion of Platypnea-Orthodeoxia Syndrome (POS). Invasive intracardiac haemodynamic assessment showed a significant
right-to-left shunt (Qp/Qs = 0.74), which confirmed the diagnosis, with subsequent closure of the intracardiac defect resulting in
immediate relief of symptoms and hypoxaemia. To our knowledge, this is the first reported case of an interatrial defect and shunt
causing Platypnea-Orthodeoxia Syndrome after transcatheter aortic valve implantation, resolved by percutaneous device closure.